Menu
GWAS Study

Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.

Painter JN, O'Mara TA, Morris AP et al.

29608257 PubMed ID
GWAS Study Type
14446 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PJ
Painter JN
OT
O'Mara TA
MA
Morris AP
CT
Cheng THT
GM
Gorman M
ML
Martin L
HS
Hodson S
JA
Jones A
MN
Martin NG
GS
Gordon S
HA
Henders AK
AJ
Attia J
MM
McEvoy M
HE
Holliday EG
SR
Scott RJ
WP
Webb PM
FP
Fasching PA
BM
Beckmann MW
EA
Ekici AB
HA
Hein A
RM
Rübner M
HP
Hall P
CK
Czene K
DT
Dörk T
DM
Dürst M
HP
Hillemanns P
RI
Runnebaum I
LD
Lambrechts D
AF
Amant F
AD
Annibali D
DJ
Depreeuw J
VA
Vanderstichele A
GE
Goode EL
CJ
Cunningham JM
DS
Dowdy SC
WS
Winham SJ
TJ
Trovik J
HE
Hoivik E
WH
Werner HMJ
KC
Krakstad C
AK
Ashton K
OG
Otton G
PT
Proietto T
TE
Tham E
MM
Mints M
AS
Ahmed S
HC
Healey CS
SM
Shah M
PP
Pharoah PDP
DA
Dunning AM
DJ
Dennis J
BM
Bolla MK
MK
Michailidou K
WQ
Wang Q
TJ
Tyrer JP
HJ
Hopper JL
PJ
Peto J
SA
Swerdlow AJ
BB
Burwinkel B
BH
Brenner H
MA
Meindl A
BH
Brauch H
LA
Lindblom A
CJ
Chang-Claude J
CF
Couch FJ
GG
Giles GG
KV
Kristensen VN
CA
Cox A
ZK
Zondervan KT
ND
Nyholt DR
MS
MacGregor S
MG
Montgomery GW
TI
Tomlinson I
ED
Easton DF
TD
Thompson DJ
SA
Spurdle AB
Chapter II

Abstract

Summary of the research findings

Epidemiological, biological, and molecular data suggest links between endometriosis and endometrial cancer, with recent epidemiological studies providing evidence for an association between a previous diagnosis of endometriosis and risk of endometrial cancer. We used genetic data as an alternative approach to investigate shared biological etiology of these two diseases. Genetic correlation analysis of summary level statistics from genomewide association studies (GWAS) using LD Score regression revealed moderate but significant genetic correlation (rg = 0.23, P = 9.3 × 10-3 ), and SNP effect concordance analysis provided evidence for significant SNP pleiotropy (P = 6.0 × 10-3 ) and concordance in effect direction (P = 2.0 × 10-3 ) between the two diseases. Cross-disease GWAS meta-analysis highlighted 13 distinct loci associated at P ≤ 10-5 with both endometriosis and endometrial cancer, with one locus (SNP rs2475335) located within PTPRD associated at a genomewide significant level (P = 4.9 × 10-8 , OR = 1.11, 95% CI = 1.07-1.15). PTPRD acts in the STAT3 pathway, which has been implicated in both endometriosis and endometrial cancer. This study demonstrates the value of cross-disease genetic analysis to support epidemiological observations and to identify biological pathways of relevance to multiple diseases.

3,194 endometriosis cases, 5,330 non-endometriosis controls, 2,057 endometrial cancer cases, 3,866 non-endometrial cancer controls

Chapter III

Study Statistics

Key metrics and study information

14446
Total Participants
GWAS
Study Type
No
Replicated
Australia, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.